Click here to view the Humana Medical Policy Updates Updates » September 2024 Humana Medical…
BCBS Federal Employee Program (FEP) Medical Policy Updates – July 2022
July 2022 BCBS Federal Employee Program (FEP) Medical Policy Updates:
- 5HT1 Agonists Triptans
- Abecma idecabtagene vicleucel
- Actemra tocilizumab 1
- Acthar gel corticotropin
- Aczone dapsone
- Adakveo crizanlizumabtmca
- Adbry tralokinumabldrm
- Amniotic Membrane and Amniotic
- Amphetamines
- Apretude cabotegravir extendedrelease injectable suspension
- ART Drugs
- Artificial Intervertebral Disc
- Artificial Intervertebral Disc
- Autologous Chondrocyte Implantation
- Axial Lumbosacral Interbody
- Baclofen oral
- Baclofen powder
- Balloon Ostial Dilation for
- Bevacizumab
- Blenrep belantamab mafodotinblmf 1
- Cabenuva cabotegravir rilpivirine
- Camzyos mavacamten
- Cardiac Rehabilitation in the Outpatient
- Carvykti ciltacabtagene autoleucel
- Celebrex celecoxib
- Chelation Therapy for Off
- Cibinqo abrocitinib
- Cimzia certolizumab pegol
- Cinqair reslizumab
- Cochlear Implant
- Cognitive Rehabilitation
- Computer Assisted Navigation
- Cooling Devices Used
- Corlanor ivabradine
- Cortrophin Gel corticotropin
- Cosentyx secukinumab
- Cryoablation Radiofrequency Ablation and
- Cyclosporine Ophthalmics
- Dartisla ODT glycopyrrolate
- Darzalex daratumumab
- Darzalex Faspro daratumumab and hyaluronidasefihj
- Decompression of the
- Dry Needling of Trigger
- Dupixent dupilumab
- Electrical and Electromagnetic Stimulation
- Electrical Bone Growth Stimulation
- Electrical Stimulation of
- Empliciti elotuzumab
- Endari Lglutamine
- Endovascular Procedures for Intracranial
- Enhertu famtrastuzumab deruxtecannxki
- Enjaymo sutimlimabjome
- Entresto sacubitril valsartan
- Evkeeza evinacumabdgnb
- Evomela melphalan
- Evrysdi risdiplam
- Evzio naloxone injection
- Eyelid Thermal Pulsation for
- Facet Arthroplasty
- Farydak panobinostat
- Fintepla fenfluramine
- Functional Neuromuscular Electrical Stimulation
- Gabapentin
- Gabapentin powder
- Galafold migalastat
- GamaSTAN IGIM
- Gamifant emapalumablzsg
- Gastric Electrical Stimulation
- Gattex teduglutide
- Gazyva obinutuzumab
- Gene Expression Bassed Assays
- Gene Expression Profiling for
- Genetic Testing for CHARGE
- Genetic Testing for Duchenne
- Genetic Testing for Epilepsy
- Genetic Testing for Familial Cutaneous
- Genetic Testing for Fasciocapuloumeral
- Genetic Testing for Hereditary
- Genetic Testing for Hereditary
- Genetic Testing for Idiopathic
- Genetic Testing for Limb
- Genetic Testing for Macular
- Genetic Testing for Marfan
- Genetic Testing for PTEN
- Genetic Testing of CADASIL
- Germline Genetic Testing for Pancreatic
- Gilenya fingolimod
- Givlaari givosiran
- Gloperba colchicine
- GnRH GD
- Grastek timothy grass pollen allergen extract
- Growth Hormone Adult
- Growth Hormones Pediatric
- Haegarda C1 esterase inhibitor human
- Halaven eribulin mesylate
- Handheld Radiofrequency Spectroscopy
- HCG
- Hemady dexamethasone
- Hepsera adefovir
- Herceptin Hylecta trastuzumab and hyaluronidaseoysk
- Hetlioz tasimelteon
- Hyaluronate Powder
- Hyaluronic Acid Derivatives
- Ibrance palbociclib
- Ibsrela tenapanor
- Icatibant
- Idhifa enasidenib
- IL5 Antagonists IgG1 kappa
- Ilaris canakinumab
- Ilumya tildrakizumabasmn
- Image Guided Minimally
- Imbruvica ibrutinib
- Imcivree setmelanotide
- Imfinzi durvalumab
- Imlygic talimogene laherparepvec
- Inbrija levodopa inhalation powder
- Increlex mecasermin
- Ingrezza valbenazine
- Inlyta axitinib
- Inqovi decitabine cedazuridine
- Inrebic fedratinib
- Insulin GLP-1 Combinations
- Interspinous and Interlaminar
- Intraocular Radiotherapy for Age
- Intraoperative Neurophysiologic Monitoring
- Intron A Hepatitis B
- Intron A Ribavirin
- IR Opioid Combo Drugs
- Isotretinoins
- Isturisa osilodrostat
- Itraconazole
- IVIG intravenous immunoglobulin
- Jakafi ruxolitinib
- Jelmyto mitomycin
- Jemperli dostarlimabgxly
- Jevtana cabazitaxel
- Juxtapid lomitapide
- Jynarque tolvaptan
- Kadcyla adotrastuzumab emtansine
- Kalbitor ecallantide
- Kalydeco ivacaftor
- Kanuma sebelipase alfa
- Kepivance palifermin
- Kerendia finerenone
- Kesimpta ofatumumab
- Ketalar ketamine
- Ketamine Powder
- Ketoconazole
- Keveyis dichlorphenamide
- Kevzara sarilumab
- Keytruda pembrolizumab
- Kimmtrak tebentafusptebn
- Kineret anakinra
- Klisyri tirbanibulin
- Korlym mifepristone
- Korsuva difelikefalin
- Koselugo selumetinib
- Krystexxa pegloticase
- Kuvan sapropterin
- Kymriah tisagenlecleucel
- Laboratory and Genetic Testing for
- Laparoscopic Percutaneous and
- Lemtrada alemtuzumab
- Lenvima lenvatinib
- Leqvio inclisiran
- Letairis ambrisentan
- Leukine sargramostim
- Leuprolide
- Libtayo cemiplimabrwlc
- Lidocaine injection
- Lidocaine Patches
- Lidocaine Topicals
- LifEMS Naloxone naloxone convenience kit
- Linzess linaclotide
- Lonsurf trifluridine tipiracil
- Low Intensity Pulsed Ultrasound
- Lucemyra lofexidine
- Lucentis ranibizumab
- Lumizyme alglucosidase alfa
- Lumoxiti moxetumomab pasudotoxtdfk
- Lupkynis voclosporin
- Lutathera lutetium LU 177 dotatate
- Luxturna voretigene neparvovecrzyl
- Luzu luliconazole
- Lybalvi olanzapine and samidorphan
- Lynparza olaparib
- Lyrica pregabalin
- Lysodren mitotane
- Manipulation Under Anesthesia
- Margenza margetuximabcmkb
- Marqibo vincristine
- Maternal Serum Biomarkers
- Mavenclad cladribine
- Maxalt rizatriptan
- Mayzent siponimod
- Medical Foods
- Medical Policies – Blue Cross and Blue Shield’s Federal Employee Program
- Mektovi binimetinib
- Meniscal Allografts and
- Mepsevii vestronidase alfavjbk
- Metformin
- Methotrexate Injections
- MicroprocessorControlled Prostheses
- Migraine Powders
- Mircera methoxy polyethylene glycolepoetin beta
- Molecular Analysis Including Liquid Biopsy
- Monjuvi tafasitamabcxix
- Motegrity prucalopride
- Mozobil plerixafor
- MS Injectables
- Mulpleta lusutrombopag
- Myalept metraleptin
- Mycapssa octreotide
- Mylotarg gemtuzumab ozogamicin
- Myobloc rimabotulinumtoxin B
- Myoelectric Prosthetic and Orthotic
- Mytesi crofelemer
- Nascobal cyanocobalamin
- Nerve Graft with Radical
- Neulasta Fulphila Nyvepria Udenyca Ziextenzo
- Neupogen Granix Nivestym Releuko Zarxio
- Nexletol Nexlizet
- Ninlaro ixazomib
- Non Invasive Positive Airway
- Oncologic Applications of PET
- Opdivo nivolumab
- Opdualag nivolumab and relatlimabrmbw
- Ophthalmic VEGF Inhibitors
- Opioid IR Drug Class
- Opthalmologic Techniques That Evaluate
- Optical Coherence Tomography
- Orilissa elagolix
- Orthopedic Applications of
- Outpatient Pulmonary Rehabilitation
- Oxbryta voxelotor
- Pepaxto melphalan flufenamide
- Percutaneous Balloon Kyphoplasty
- Percutaneous Vertebroplasty and
- Peripheral Subcutaneous Field
- Piqray alpelisib
- Pluvicto lutetium Lu 177 vipivotide tetraxetan
- Pneumatic Compression Pumps
- Pomalyst pomalidomide
- Postsurgical Home Use of
- Powered Exoskeleton for Ambulation
- Praluent alirocumab
- Pyrukynd mitapivat
- Qelbree viloxazine
- Rayos prednisone
- Recorlev levoketoconazole
- Reduction Mammaplasty for Breast
- Repatha evolocumab
- Rethymic allogeneic processed thymus tissueagdc
- Retinal Prosthesis
- Revlimid lenalidomide
- Rinvoq upadactinib
- Rituximab (1)
- Ryplazim plasminogen humantvmh
- Sarclisa isatuximabirfc
- SCIG subcutaneous immunoglobulin
- SemiImplantable and Fully
- Sensory Integration Therapy
- SGLT2 Step Policy
- Signifor LAR pasireotide pamoate
- Signifor pasireotide
- Siklos hydroxyurea
- Simponi golimumab 2
- Skyrizi risankizumabrzaa
- Soliris eculizumab
- Spinraza nusinersen
- Stelara ustekinumab
- Subtalar Arthroereisis
- Surgical Treatment of
- Surgical Treatment of Bilateral
- Susvimo ranibizumab
- Tarpeyo budesonide
- Tazarotene
- Tecartus brexucabtagene autoleucel
- Temporomandibular Joint Disorder
- Testosterone Oral Buccal Nasal Agents
- Tezspire tezepelumabekko
- Topical Corticosteroids
- Transcatheter Aortic Valve Implantation
- Trastuzumab
- Tretinoin
- Tumor Informed Circulating Tumor
- Ultomiris ravulizumabcwvz
- Velcade bortezomib
- Verquvo vericiguat
- Vertebral Axial Decompression
- Vertical Expandable Prosthetic
- Vijoice alpelisib
- Vivjoa oteseconazole
- Vonjo pacritinib
- Vuity pilocarpine
- Whole Exome and Whole Genome
- Winlevi clascoterone
- Xeljanz tofacitinib
- Xolair omalizumab
- Xpovio selinexor
- Yescarta axicabtagene ciloleucel
- Zeposia ozanimod
- Zolgensma onasemnogene abeparvovecxioi
- Ztalmy ganaxolone
Policy Alerts monitors Commercial and Medicare medical policies for changes. While medical Insurance carriers typically update medical policies annually, there are many reasons why they might review or update a policy. When reviews occur out of cycle they often go unnoticed. Policy Alerts keeps you updated when Payers make coverage changes to medical policies affecting your business.
Policy Alerts continuously monitors Commercial and Medicare Payer coverage information to keep you up-to-date on medical Insurance decisions in real-time. When changes occur, instant email alerts are delivered to your inbox. Clients have access to detailed coverage reports and medical policies through the interactive Policy Alerts Dashboard portal. Save time each month and keep focused on important Payer medical policy reviews and coverage decisions affecting your business!
Policy Alerts takes a client-focused hands-on approach and is constantly working to provide our customers with helpful insights and actionable analytics. We understand what our clients need and are dedicated to providing timely, accurate, and always up-to-date reports.
Health economic and reimbursement information provided by Policy Alerts is gathered from third-party sources and is subject to change without notice as a result of complex and frequently changing laws, regulations, rules and policies. All product and company names are trademarks™ or registered® trademarks of their respective holders. Use of them does not imply any affiliation with or endorsement by them. This information is presented for illustrative purposes only and does not constitute reimbursement or legal advice.
Related Posts
